Seth Duncan has led research and analytics teams for over 10 years in both academic and business settings. Since 2007, Seth has focused on using digital and social media data to provide marketing, communications, and strategy insights to a range of clients, including Warner Bros., General Mills, Procter & Gamble, IBM, HP, Medtronic, Genentech, Amgen, and Abbott Laboratories.
Seth’s analytics and research expertise span advanced statistics, social, digital, and Web analytics, as well as traditional media and primary research. He has extensive experience applying these analytics approaches to a broad set of use cases, including product development and design, branding, creative content and execution, messaging, social and Web optimization, and influencer and media relations. He was named one of Holmes Report’s “In2 Innovators of the Year” in 2015.
Seth earned a BA in psychology from Reed College and an MS in Psychophysiology at San Francisco State University. He also attended Boston College’s PhD program in cognitive, affective, and behavioral neuroscience and the Harvard-MIT Health Sciences and Technology graduate program.
Managing Director, Analytics, W2O
Chuck Hemann is currently the Managing Director and Head of Digital Analytics at W2O.
Over the last 14+ years Chuck has provided strategic counsel to clients on a variety of topics including digital analytics, measurement, social media, online reputation and crisis communications. Prior to joining W2O, Chuck was the Director of Digital Analytics at Intel where he managed all the paid media, web, search and social analytics programs globally. During his tenure at Intel he changed the way the company measured paid media, Intel.com and social media, co-led the company’s development of its first Digital Hub in Singapore, grew the team by five additional team members to cover expanded global scope, managed an agency network that consistently received the highest grades in all of marketing, led an initiative to consolidate the company’s social footprint which saved the organization more than $2 million and was an active counselor to the CMO and his staff on insights and measurement.
Chuck is a former Fellow of the Society for New Communications Research, a global, non-profit research and education foundation think tank focused on the latest developments in media and communications. He’s also the co-author of Digital Marketing Analytics: Making Sense of Consumer Data in a Digital World (Version 2), which was released in May 2018. .
Chuck is an active participant in the Chief Analytics Officer Advisory Council, which is part of ICOM Global.
He’s also a frequent speaker on the topics of digital analytics, measurement, social listening and digital marketing at events around the world.
Chuck holds a bachelor’s degree in political science from Baldwin-Wallace College and a master’s in applied politics from the University of Akron. He’s a former board member of the National Investor Relations Institute, and has been active in several industry associations throughout his career.
President, W2O marketeching
W2O Group acquired Marketeching in November 2016, adding to its healthcare expertise while strengthening its analytics to include more qualitative approaches with W2O’s more quantitative specialties, which serves as the perfect complement to W2O’s increasingly expansive MDigitalLife platform. Kevin remains the President of Marketeching.
Kevin founded Marketeching in 2008 with the goal of helping healthcare companies understand how their key stakeholders engage on social media in key communities. Marketeching initially focused on providing clients with a platform to view and analyze engagements in real time, but Kevin pivoted the company in 2010 based on client feedback and foreseeing trends in the social analytics market that showed social media monitoring platforms becoming commoditized, making them only one piece of the puzzle in understanding customer engagement on social media. Kevin believed the real value would be in the ability to analyze those engagements through a more hands-on approach.
Under Kevin’s leadership, Marketeching grew into a 20-person research and analytics firm with a specialization in analyzing social data with unique qualitative approaches. Today, Marketeching is a trusted partner in social media research and analytics for a variety of healthcare companies and clients. They have an emphasis in working with marketers, market researchers, digital strategies, and public affairs.
Kevin received his degree in marketing from The Eli Broad College of Business at Michigan State University. He resides in New Hope, Pennsylvania, with his wife Caitlin and identical twin boys, Brayden and Parker.
Founder & Chief Executive Officer, W2O
Jim has nearly 30 years of experience in strategic media and marketing communications, focused primarily in the healthcare and technology sectors. He has been involved in nearly every aspect of corporate, product, and organizational communications.
He ranks among the 500 Most Important People in the Global PR Industry (2015, 2017) and PRWeek’s Powerlist (2012, 2013, 2014) and was named a Top 25 Innovator in Communications (2014). Recently, he was appointed to the Board of Trustees of the Cancer Research Institute, where he serves on the Marketing Subcommittee.
Jim is also a founder and sponsor of the W2O Center for Social Commerce at the Newhouse School of Public Communications at Syracuse University, his alma mater. The Center has become a leading academic program aimed at providing students with modern media analytics and digital insight and skills to set them apart from their peers. He was inducted into the Newhouse School’s Hall of Fame and honored as one of its 50Forward most accomplished graduates of the last 50 years.
In 2016, Jim partnered with Kim Hunter at The LAGRANT Foundation (TLF) to form the first-of-its-kind paid healthcare fellowship that places ethnic minorities pursuing careers in healthcare communications in one of W2O’s offices. He is committed to diversifying the workforce and currently sits on the Board of Directors at TLF.
Jim spent most of the first half of his career as a client, which inspired him to build an agency he would want to hire. Before starting his own firm, Jim was head of corporate communications and investor relations at Bay Area medical device start-up Heartport, a pioneer in minimally invasive cardiac surgery. Prior to that, he helped establish the global product marketing communications function at pharmaceutical giant Sanofi in Paris. He started his corporate career at biotechnology bellwether Genentech in South San Francisco during its formative commercial years in the early 1990s. While there, he supported the marketing, sales, investor relations, government affairs, and communications functions.
He resides with his wife and two children in the San Francisco Bay Area, where W2O is headquartered.
Chief Business Development Officer, W2O
A seasoned marketing and communications leader with 20 years of experience, Anita has a proven track record of excellent client service and success in growth of corporate, product, and financial marketing communications for clients around the world, in industries including biopharmaceutical, consumer health, financial services, and technology. At W2O Group, she is responsible for building and leading entrepreneurial, client-focused teams charged with propelling the development and execution of innovative solutions on top of W2O Group’s communications, analytics, and integrated offerings.
Anita’s passion for creative program development focuses on developing new and thoughtful solutions to her clients’ greatest business challenges. She has worked with companies such as Bayer, Nestle, Pfizer, GlaxoSmithKline, First Union, WebMD, and Genentech, to name a few.
Previously, Anita was Chief Strategist at Cooney/Waters Group, a boutique healthcare communications firm focused on providing senior strategic counsel to a range of health and wellness clients. Prior to that, she was Vice President of External Communications for inVentiv Health, where she managed corporate and financial communications for the $2 billion healthcare services company. Anita also held major leadership roles at global communications firms MSLGROUP, Cohn & Wolfe, and Robinson Lerer & Montgomery (now Finsbury), a boutique crisis and corporate communications agency.
Anita holds both an MBA and a Master of Public Health degree from Columbia University. She is also on the board of advisors for Samhati, a nonprofit group focused on improving the social and economic conditions of women and children in Bangladesh.
E. Fredkin University Professor of Machine Learning and Computer Science, Carnegie Mellon University
Tom M. Mitchell is the Founders University Professor in the School of Computer Science at Carnegie Mellon University, where he created the world's first academic Machine Learning Department. Mitchell’s research explores machine learning theory, algorithms and applications, as well as the impact of AI on society. He has testified to the U.S. Congress several times on AI impacts on society, and he co-chaired the 2017 U.S. National Academy study on “Information Technology, Automation, and the U.S. Workforce.” Mitchell advises a variety of young and old companies internationally on their AI product and business strategies, and his research has been featured in popular press from the New York Times, to CCTV (China's national television network), to CBS's 60 Minutes. He is a member of the U.S. National Academy of Engineering, a member of the American Academy of Arts and Sciences, and a Fellow and Past President of the Association for the Advancement of Artificial Intelligence (AAAI).
Joseph Habboushe, MD MBA
Chief Executive Officer, MDCalc
Joseph Habboushe, MD MBA, is a practicing emergency physician and associate professor at New York University Langone Medical Center and Bellevue Medical Centers in New York City. He is the CEO and co-founder of MDCalc. MDCalc is used by 65%+ of all US docs monthly. Dr. Habboushe is also the creator and editor-in-chief of the pocket guide series, The Basics of Emergency Medicine, published by the Emergency Medicine Residents' Association.
Chief Marketing Officer, Aetion
Liz DeMatteis is the Chief Marketing Officer at Aetion. Over her 20+ years in health care transformation, Liz has tackled many go-to-market challenges across a number of high-growth, high-tech firms.
She is able to lead, challenge and be challenged in roles of marketing, strategy and business development across a number of high-growth, high-tech companies. She is skilled in analyzing and improving marketing, sales and operational performance, and in developing brands, products, communications, markets and relationships.
Most recently, Liz served as a member of Grand Rounds' executive team and led the company's marketing function. Prior executive roles span health technology companies of all shapes and sizes, including Evolent Health, Medtronic, and W2O, a life sciences-focused marketing firm. Liz has also tackled diverse commercialization challenges, from leading global medical device launches to building brand value for digital health startups.
She holds a bachelor’s degree in psychology from the University of Montana, her home state, and an M.B.A. from the University of Washington Foster School of Business. She lives in Washington, D.C. with her husband, Carey, and their sons, Teddy and Archie. Liz believes in the power of story and in finding time to do nothing.
Chief Executive Officer, Symplur
Audun Utengen is the co-founder and Chief Executive Officer of Symplur. He is building technology that aims to lift up voices that need to be heard in healthcare. By surfacing insights from the Healthcare Social Graph®, Audun and his team are working to promote a deeper understanding of healthcare for those with a willingness to listen to the ideas of patients, providers and other stakeholders.
In 2016, Audun was invited to the White House as part of President Obama’s Precision Medicine Initiative.
Audun has presented and held workshops at healthcare conferences both in the U.S. and Europe (Stanford Medicine X, Mayo Clinic Transform Symposium, Health Datapalooza, Doctors 2.0 & You). His research efforts have been published in several academic journals including the British Medical Journal (BMJ).
With his formal education, Audun has gained a unique perspective from completing his studies in Norway, Denmark, China, and the United States.
Former Chief Communications Officer, Vertex
Kym White is the former Chief Communications Officer at Vertex with substantial agency experience; expertise in corporate communications, issues and crisis management, product marketing, media relations and executive positioning. Deep knowledge of healthcare industry informed by work across industry verticals including pharmaceuticals and biotechnology as well as established and emerging companies. Strong client service mentality informed by 20+ years of leadership roles in the world's largest public relations firms. Recognized for attracting and developing talent and for impact in both functional and matrixed team environments.
Dan Donovan is the Founder & CEO of rareLife Solutions. He has spent nearly 3 decades in the pharmaceutical industry on both the industry and service sides of the business – first with Pfizer then creating Envision Pharma, which was acquired by United BioSource Corporation. Dan’s introduction to the world of rare disease began in 2011 when he was appointed to the Board of Directors and later as Chief Business Officer of Cancer Prevention Pharmaceuticals. Dan is the primary visionary behind rareLife solutions.
Dan’s experiences and observations have led him to believe that there is a better, smarter way to engage all rare disease stakeholders and accelerate disease understanding and treatment success. He believes the power of collaboration is the linchpin to this fundamental change.
Editor In Chief, MM&M
Steve Madden is Editor In Chief at MM&M. He is a skilled editorial and content strategist and leader with expertise at managing the nexus of creativity and commerce, regardless of the medium. He is an expert at editorial management and has a proven track record of success.
He can make great content—films, videos, books, articles—that gets attention, informs readers so they can live better lives, and touches the mind as well as the soul. Stories drive engagement, and he is an expert story-teller.
Steve can help you grow your audience and engage with them as well as your customers and clients in new ways, across the platform that's appropriate for the story we're telling.
Head of Marketing, Cedar
Bethany Hale is the Head of Marketing at Cedar, a data-driven patient payment and engagement platform that is transforming the financial experience for more than 150,000 patients nationwide on behalf of its clients. She brings 15+ years of experience across marketing strategy, brand development, content and performance marketing, and customer experience design to this role.
Prior to joining Cedar, Bethany spent 7 years at IBM, most recently as a product manager on the healthcare team where she created an AI-enhanced, pre-configured marketing automation platform, in partnership with Adobe, that enables healthcare & life sciences marketers to drive improved healthcare consumer experiences, increased revenue and more effective marketing campaigns.
Bethany is a creative storyteller and thought leader who has worked with other notable brands including American Express, Samsung Electronics, Hertz, Pfizer, Microsoft, and Chevron. She has an M.B.A. from Columbia Business School and a B.A. in Journalism from Michigan State University.
Director, Digital Content, Pfizer
Ellen Gerstein leads above-brand digital and social content strategy as a part of Pfizer's Global Media Relations and Digital Communications team. She is an accomplished marketer and communicator with a vast background in creating successful social media engagement strategies and impactful marketing. Prior to Pfizer, she held leadership positions at companies in a diverse range of industries, including publishing, non-profit, and media. Her most cocktail party-conversation-worthy role was Head of Global Social Media and "For Dummies" Brand Manager (yes, the yellow and black books) at Wiley Publishing.
Chief Strategy Officer, W2O
Jeff brings over 18 years of marketing experience in pharmaceuticals, biotechnology, medical device and digital health. An experienced and results-driven marketing strategist with a proven track record of growing businesses, developing omni-channel marketing initiatives across a diverse set of categories including oncology, diabetes, women’s health and cardiovascular diseases.
In 2008 Jeff co-founded Sentient with a singular focus – identifying the right strategy to drive results for clients. Here he lead Strategy and Activation, a role he has carried through to W2O after the 2016 merger.
Jeff graduated from the University of Southern California with a Bachelor of Arts in Film & Television Production. In his free time he is a mentor for iMentor, a non-profit that builds mentoring relationships to empower students in low-income communities to graduate high school, succeed in college and achieve their ambitions.
Managing Director, Value & Access, W2O
Leslie Isenegger brings nearly two decades of experience in public affairs, corporate communications, issues management, and public relations. Her expertise includes supporting clients undergoing value framework assessments and preparing clients for pricing and market access challenges. Since 2016, Leslie has supported client value communications for a dozen new drug approvals and 70% of all ICER therapeutic category reviews. She has also published, spoken, and moderated industry panels on HTAs, ICER’s rare disease framework, and the future of value-based reimbursement.
Leslie has an extensive background in healthcare policy, working for the U.S. Department of Health and Human Services in the Public Affairs and Legislative Offices; she also served as chief speechwriter for the Centers for Medicare & Medicaid Services and had a pivotal role in executing the national roll-out of the Medicare Part D benefit. Leslie also led Corporate Communications at GNYHA Ventures, the privately held for-profit arm of the Greater New York Hospital Association (GNYHA). In this role, she oversaw public relations and corporate messaging for GNYHA’s trade association function, as well as its family of five active companies. Leslie’s work included responding to emergent advocacy issues, preparing the group’s public messaging around the Affordable Care Act, managing stakeholders throughout the healthcare supply chain, and overseeing the sale of GNYHA’s wholly owned digital health company.
Leslie graduated from Georgetown University with a BA in Economics & Government and a Master’s in Health Policy from Georgetown’s McCourt School of Public Policy. She earned an executive MBA from Harvard Business School in the Program for Leadership Development, a Certificate in Public Relations from NYU, and a Certificate in Creating Shared Value (CSV) from Harvard Business School.
Vice President, Patient Advocacy and Stakeholder Management, Otsuka
Mary Michael is Vice President of Stakeholder Management & Patient Advocacy at Otsuka America Pharmaceutical, Inc. (OAPI). She has the unique opportunity to work with trailblazing leaders both inside and outside the clinic walls to create innovative patient-centered solutions. It is her responsibility to understand how the world is changing across multiple disease categories, and she pulls together the thoughts, ideas, and research from a global array of key opinion leaders, patient advocates, technologists, caregivers, and others to incubate novel business solutions. Mary brings innovation to Otsuka by engaging with stakeholders from the world’s most prestigious medical centers as well as local advocacy chapters.
Before coming to Otsuka, Mary spent nine years with Wyeth in Opinion Leader and Advocacy Relations, where she developed and executed their global opinion leader business strategies across the specialty products portfolio. Prior to Wyeth, she was with Bristol-Myers Squibb for 13 years in a variety of positions. At Otsuka, Mary has spearheaded the launch of the Global Council on Alzheimer’s Disease (GCAD), a collection of preeminent experts who influence the Alzheimer’s space, including science, medicine, technology, policy, advocacy, and caregiving. Through GCAD, she has jumpstarted technological innovation, framed a patient navigation model for Alzheimer’s disease, and helped improve communication between families and healthcare providers.
Mary is a graduate of both Virginia Tech and Singularity University.
Global Medical Information Leader, Roche
Joerg Corsten is Principal Digital Medical Engagement in Global Product Strategy Digital Excellence at Hoffman-La Roche AG, Basel, Switzerland. The focus of his work is on the close collaboration between the development and medical functions in order to do now what patients needs next across all customer groups such as patients, caregivers, physicians and pharmacists. He started his journey with Roche in the German affiliate in 2001 and worked mostly in customer-centric functions such as Customer Care, Dataservice & Credit Management, Campaign Management, Established Products, and eMarketing. I 2014 he started in the global HQ in Basel both as a digital strategist as well as a group lead for digital services. Joerg Corsten has studied economy and business administration both at the University of Freiburg and the University of Cooperative Education / Duale Hochhschule Baden-Wurttemberg.
Co-Founder, W2O arcus
Mary is the Co-Founder of W2O arcus. Having trained as an oncologist, Mary brings a physician’s perspective to the mix at Arcus—a critical factor in our effective communications to HCPs. A distinct complement to her experience treating patients with cancer, her background as an immunologist gives Mary deep insight into the complex biology behind the targeted oncology products of today.
Before joining Arcus, Mary worked as Medical Director at Genentech, Cephalon, and GSK, leading the development of oncology products such as Rituxan, Treanda, and other pre-launch agents. Mary’s residency was at the Children’s Hospital, Harvard University, which led to a fellowship at Memorial Sloan-Kettering Cancer Center. She holds a PhD in immunology from NYU, and an undergraduate degree in Molecular Biology from Princeton University.
Managing Director, Analytics, W2O
Laura is a seasoned analytics leader and client partner with extensive experience in data-driven business consulting across multiple research methodologies, industries and geographies. She currently serves as Managing Director, Analytics and Insight at W2O, in which capacity she leads the EMEA analytics business, providing strategic counsel to our global client base. She has worked across multiple indications, therapy areas, brands and stages of the product lifecycle – predominantly in the pharma and diagnostics fields, but also across biotech and consumer health.
Laura has a particular interest in helping clients successfully to navigate the complexities of the global digital landscape by leveraging actionable insight into how target audiences behave, both online and off, and what to do as a result. Having led global and regional teams for over 15 years, she is attuned to optimizing outcomes in an international context.
Prior to joining W2O, Laura held a variety of insights-driven leadership roles at companies including M&C Saatchi, the Guardian and IDC. She has also worked as a marketing strategist, a management consultant and a policy adviser in sustainable development and human rights. She graduated from London School of Economics with a Masters in European Political Economy and holds a joint honors Law & Sociology degree from the University of Exeter.
Unusually for a Brit, Laura is a polyglot. Outside of work, she loves to read, travel and entertain – and, true to her research roots, is always trying to acquire knowledge and puzzle new things out!